Abigail Woodfin

3.3k citations
24 papers · 2.6k indexed · h-index 19

Abigail Woodfin

24 papers receiving 2.5k citations

Peers

Abigail Woodfin
Comparison fields: 5 of 102
  • Immunology and Allergy 768
  • Immunology 1.2k
  • Neurology 335
  • Cell Biology 279
  • Hematology 175
Replace F Breviario with:
F Breviario Italy
Erik Mul Netherlands
Ferruccio Breviario Italy
JD Chambers United States
Valentin P. Yakubenko United States
F W Luscinskas United States
R Pigott United Kingdom
Rajita Pappu United States
Maike Frye Germany
Elżbieta Pluskota United States
Abigail Woodfin relative to F Breviario Italy F Breviario's profile →
Citations per field
00.5×7.0×
F Breviario · 1×
Citations per year

Countries citing papers authored by Abigail Woodfin

Since Specialization
Citations

This map shows the geographic impact of Abigail Woodfin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abigail Woodfin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abigail Woodfin more than expected).

Fields of papers citing papers by Abigail Woodfin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abigail Woodfin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abigail Woodfin. The network helps show where Abigail Woodfin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Abigail Woodfin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Abigail Woodfin Line = papers co-authored together Abigail Woodfin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201929
2 2016108
3 201617
4 201632
5 2015199
6 201533
7 201462
8 20141
9 201343
10 201337
11 2012371
12 201116
13 2011458
14 201022
15 2009156
16 200999
17 200995
18 2007114
19 2007435
20 200693

About Abigail Woodfin

Abigail Woodfin is a scholar working on Immunology and Allergy, Immunology and Neurology, having authored 24 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (16 papers), Immune Response and Inflammation (12 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers), Angiogenesis and VEGF in Cancer (4 papers), Platelet Disorders and Treatments (3 papers), Barrier Structure and Function Studies (2 papers), Protease and Inhibitor Mechanisms (2 papers) and Neuropeptides and Animal Physiology (2 papers). The work is most often cited by research in Immunology and Allergy (768 citations), Immunology (1.2k citations) and Neurology (335 citations). Abigail Woodfin has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Sussan Nourshargh, Mathieu-Benoı̂t Voisin, James R. Whiteford, Martina Beyrau, Beat A. Imhof, Bartomeu Colom, Triantafyllos Chavakis, Gareth E. Jones, David W. Rowe and Fulvio D’Acquisto. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026